1 completed, 1 recruiting. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Cefoxitin: new trials by email Literature Review of Cefoxitin trials Research Report on Cefoxitin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Finding the Optimal Regimen for Mycobacterium Abscessus Treatment Amikacin, Tigecycline, Imipenem - Pulmonary Disease Due to Mycobacteria (Diagnosis) | Phase 2 / Phase 3 | Recruiting | The University of Queensland | 300 | 2020-03-02 | 2026-05-11 |
| Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy? Cefoxitin, Piperacillin-tazobactam - Pancreatic Cancer, Pancreas Cancer | Phase 3 | Completed | Memorial Sloan Kettering Cancer Center | 967 | 2017-11-21 | 2025-10-21 |
Disease (1) · Lung Diseases (1) · Mycobacterium Infections, Nontuberculous (1) · Pancreatic Diseases (1) · Pancreatic Neoplasms (1)
Memorial Sloan Kettering Cancer Center (1) · The University of Queensland (1)
Australia (1) · Canada (1) · Denmark (1) · Israel (1) · Netherlands (1) · Singapore (1) · Taiwan (1) · United Kingdom (1) · United States (1)